-
Apple, Google Coronavirus Tech Won't Track Your Location. That Worries Some States.
Apple and Google are developing smartphone technology to help fight the coronavirus pandemic. But public health authorities in some states are chafing against the tech giants' rules. -
How The New England Aquarium 'First Responders' Are Caring For 20,000 Animals During The Pandemic
The doors are shut to visitors, but inside the aquarium, life goes on. -
In Settlement, Facebook To Pay $52 Million To Content Moderators With PTSD
As part of a settlement agreement, more than 10,000 moderators who viewed and removed graphic and disturbing posts, and consequently suffered post-traumatic stress disorder, are eligible for payouts. -
Market For Blood Plasma From COVID-19 Survivors Heats Up
As many firms and academic researchers vie for blood donations from survivors in hopes of isolating components for new treatments, one project is turning for help from 10,000 Orthodox Jewish women. -
The Slow Burn Of A Long-Term Slowdown
The world has been experiencing all kinds of slowdown for decades now. -
The Coronavirus Is Mutating. That's Normal. Does That Mean It's More Dangerous?
There are various studies looking at changes to the virus genome — and the possible impact on how the virus affects humans. Here's what we know (and don't yet know) about mutations. -
Putting A Price On COVID-19 Treatment Remdesivir
Gilead Sciences has committed to donating the initial supply of the experimental antiviral drug. But executives said the company will need to make expanded production of the treatment sustainable. -
From Loss Of Smell To 'COVID Toes': What Experts Are Learning About Symptoms
It's not just a fever and dry cough. For milder cases of COVID-19, the array of symptoms can include headaches, fatigue, loss of smell and even lesions on the feet known as "COVID toes." -
Whistleblower: Trump Team Ignored Warnings On Drug, Virus
Rick Bright filed a complaint Tuesday with the Office of Special Counsel, a government agency responsible for whistleblower complaints. -
Northwestern Doctor Says He Has 'Hope And Optimism' Experimental Treatment Remdesivir Will Save Lives
Dr. Babafemi Taiwo, the chief of infectious diseases at Northwestern Medicine, said the antiviral drug has shown a trend toward “improvement in survival.”
